| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
209,920,000 |
| Market
Cap: |
1.66(B) |
| Last
Volume: |
3,901,941 |
Avg
Vol: |
4,148,128 |
| 52
Week Range: |
$6.41 - $11.19 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1115 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
183,601 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,048,338 |
| Total People Bought |
0 |
0 |
0 |
10 |
| Total Buy Transactions |
0 |
0 |
0 |
10 |
| Total Shares Sold |
214,263 |
284,263 |
284,263 |
295,650 |
| Total Sell Value |
$1,562,332 |
$2,158,200 |
$2,158,200 |
$2,227,259 |
| Total People Sold |
2 |
3 |
3 |
3 |
| Total Sell Transactions |
6 |
7 |
7 |
9 |
| End Date |
2025-10-09 |
2025-07-08 |
2025-01-07 |
2024-01-08 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Barnes Alane P |
Chief Legal Officer |
|
2025-12-22 |
4 |
AS |
$7.65 |
$166,563 |
D/D |
(21,773) |
398,751 |
|
-1% |
|
Gayer Charles K |
President and CCO |
|
2025-12-22 |
4 |
OE |
$3.22 |
$371,896 |
D/D |
74,233 |
952,583 |
|
- |
|
Barnes Alane P |
Chief Legal Officer |
|
2025-12-19 |
4 |
D |
$7.41 |
$125,244 |
D/D |
(16,902) |
420,524 |
|
- |
|
Stonehouse Jon P |
Chief Executive Officer |
|
2025-12-19 |
4 |
D |
$7.41 |
$457,886 |
D/D |
(61,793) |
1,323,429 |
|
- |
|
Gayer Charles K |
President and CCO |
|
2025-12-19 |
4 |
D |
$7.41 |
$85,045 |
D/D |
(11,477) |
878,350 |
|
- |
|
Stonehouse Jon P |
Chief Executive Officer |
|
2025-12-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,000 |
40,000 |
|
- |
|
Stonehouse Jon P |
Chief Executive Officer |
|
2025-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
1,385,222 |
|
- |
|
Barnes Alane P |
Chief Legal Officer |
|
2025-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
121,700 |
437,426 |
|
- |
|
Ghias Babar |
Chief Financial Officer |
|
2025-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
121,700 |
268,700 |
|
- |
|
Gayer Charles K |
President and CCO |
|
2025-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
471,000 |
889,827 |
|
- |
|
Barnes Alane P |
Chief Legal Officer |
|
2025-12-15 |
4 |
AS |
$7.65 |
$162,257 |
D/D |
(21,210) |
315,726 |
|
-1% |
|
Stonehouse Jon P |
Chief Executive Officer |
|
2025-12-12 |
4 |
D |
$7.57 |
$207,176 |
D/D |
(27,368) |
1,405,222 |
|
- |
|
Barnes Alane P |
Chief Legal Officer |
|
2025-12-12 |
4 |
D |
$7.57 |
$64,648 |
D/D |
(8,540) |
336,936 |
|
- |
|
Gayer Charles K |
President and CCO |
|
2025-12-12 |
4 |
D |
$7.57 |
$61,930 |
D/D |
(8,181) |
418,827 |
|
- |
|
Barnes Alane P |
Chief Legal Officer |
|
2025-12-03 |
4 |
AS |
$7.65 |
$151,241 |
D/D |
(19,770) |
345,476 |
|
-4% |
|
Barnes Alane P |
Chief Legal Officer |
|
2025-12-02 |
4 |
AS |
$7.21 |
$367,216 |
D/D |
(50,906) |
365,246 |
|
5% |
|
Barnes Alane P |
Chief Legal Officer |
|
2025-12-01 |
4 |
AS |
$7.10 |
$646,511 |
D/D |
(91,004) |
416,152 |
|
5% |
|
Barnes Alane P |
Chief Legal Officer |
|
2025-12-01 |
4 |
OE |
$3.22 |
$293,033 |
D/D |
91,004 |
507,156 |
|
- |
|
Milano Vincent |
Director |
|
2025-11-28 |
4 |
A |
$7.18 |
$5,622 |
D/D |
783 |
91,219 |
|
- |
|
Frank Steven |
Director |
|
2025-11-28 |
4 |
A |
$7.18 |
$11,244 |
D/D |
1,566 |
17,618 |
|
- |
|
Mckee Amy E |
Director |
|
2025-11-28 |
4 |
A |
$7.18 |
$5,622 |
D/D |
783 |
41,790 |
|
- |
|
Sanders Machelle |
Director |
|
2025-11-13 |
4 |
AS |
$7.14 |
$68,544 |
D/D |
(9,600) |
30,642 |
|
9% |
|
Milano Vincent |
Director |
|
2025-08-29 |
4 |
A |
$8.31 |
$5,618 |
D/D |
676 |
90,436 |
|
- |
|
Mckee Amy E |
Director |
|
2025-08-29 |
4 |
A |
$8.31 |
$5,618 |
D/D |
676 |
41,007 |
|
- |
|
Frank Steven |
Director |
|
2025-08-29 |
4 |
A |
$8.31 |
$11,243 |
D/D |
1,353 |
16,052 |
|
- |
|
476 Records found
|
|
Page 1 of 20 |
|
|